HealthEquity (NASDAQ:HQY) Issues Earnings Results, Misses Estimates By $0.16 EPS

HealthEquity (NASDAQ:HQY) issued its quarterly earnings data on Tuesday. The company reported $0.55 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.16), Zacks reports. HealthEquity had a return on equity of 9.70% and a net margin of 8.41%.

HealthEquity Price Performance

Shares of NASDAQ:HQY traded up $0.95 on Tuesday, reaching $101.67. 1,940,977 shares of the company traded hands, compared to its average volume of 661,188. HealthEquity has a fifty-two week low of $65.01 and a fifty-two week high of $115.59. The company’s 50 day moving average is $105.76 and its 200-day moving average is $95.51. The stock has a market capitalization of $8.81 billion, a PE ratio of 93.28, a P/E/G ratio of 1.60 and a beta of 0.62. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on HQY. Mizuho began coverage on HealthEquity in a report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price objective for the company. Raymond James upped their target price on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research report on Tuesday, February 25th. JMP Securities upped their target price on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research report on Tuesday, December 10th. Barrington Research restated an “outperform” rating and issued a $112.00 target price on shares of HealthEquity in a research report on Friday. Finally, Wells Fargo & Company upped their target price on HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 26th. One research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat.com, HealthEquity currently has a consensus rating of “Moderate Buy” and an average target price of $112.92.

Insider Activity

In other news, Director Robert W. Selander sold 5,750 shares of the stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the sale, the director now owns 78,219 shares in the company, valued at $8,704,992.51. This represents a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 2.20% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.